UNSPSC 51191942: Thiamine hydrochloride

This classification denotes a b vitamin with the molecular formula C12H17N4OS.Cl. ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M572600E5P, chemically known as 67-03-8 (chloride, hcl) but more generally known as thiamine hcl, which bears US NIH Compound Identifier 1130. European Medicines Agency schedules Thiamine hcl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04798MIG. Most nations, for tariff and trade purposes, schedule thiamine hydrochloride under HS 29362200 and SITC 54113.

As of Q4 2014, THIAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Thiamine hydrochloride bears US NLM identifiers UMLS ID C0770309 and NCI Concept Code C48025. SMILES: CC1C(SC[N+]1CC2CNC(NC2N)C)CCO.CL.[CL-].

UNSPSC 51191942 Thiamine hydrochloride is a Commodity code for pharmaceutical and chemical supply to state and local government facilities, though recent opportunities show the code captures a broader range of chemical and pharmaceutical procurement than the specific product name suggests. State and local governments soliciting under this code are buying generic pharmaceuticals, over-the-counter products, and specialized chemicals for water treatment and healthcare operations. Issuing bodies include municipal utilities (water pollution control facilities), state departments of administration managing cooperative purchasing alliances, and multistate purchasing groups coordinating supply across member jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant buyer consolidating demand across participating state and local facilities in multiple states including Oregon.

Geographic activity centers on the Upper Midwest and Northeast. The City of Meriden, Connecticut issued an IFB for sodium bisulfite chemical supply for its Water Pollution Control Facility with bids due July 29, 2026 (Solicitation B027-15). MMCAP issued an RFP to establish multiple contracts for generic pharmaceuticals and OTC products with proposals due March 26, 2026 (Solicitation S1070000015802), specifying distribution through three authorized wholesalers with contract term effective July 1, 2026. Vendors responding to MMCAP must achieve cGMP certification and DSCSA compliance, maintain relationships with at least two of three specified wholesalers, and accept a 3 percent administrative fee on all contract purchases, with pricing weighted at 75 percent of evaluation scoring.